Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of clotrimazole + clindamycin ovules versus metronidazole + nystatin vaginal cream for mixed vaginitis
2011-003147-22Phase 3Completed
- Sponsor
- Glenmark Pharmaceuticals
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clindamycin + clotrimazole, metronidazole, nystatin in mixed vaginitis, bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), sponsored by Glenmark Pharmaceuticals. Started Aug 2011; status: completed.
02
Drugs
clindamycin + clotrimazolemetronidazolenystatin
03
Conditions
mixed vaginitisbacterial vaginosis (BV)vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on 2011-003147-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003147-22.